Medicare lays out the bureaucracy it will need to negotiate drug prices

Stat News

29 September 2022 - New documents outline how Medicare is planning to build out a sizeable new bureaucratic infrastructure to handle its new power to negotiate drug prices and penalise drug makers for price hikes.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Medicare , Pricing